HEDIS 2013 Final NDC Lists

NOTES:

  • Several NDC lists and medication tables are used for multiple products. The NDC lists reference the table names used in the Technical Specifications for Health Plans and Technical Specifications for Physician Measurement. When a list/table applies to additional products, it is noted below.
  • Changes have been made to some tables subsequent to the release of the technical specifications and are described in the Medication Table word documents.
  • Other NDC codes that match generic name, strength/dose and route indicated in the posted NDC lists may be mapped for use in HEDIS reporting. Please refer to the general guidelines for Mapping Proprietary or Other Codes section for additional information.
 

HEDIS 2013 NDC LISTS

 

HEDIS 2013 NDC Lists and Updated Medication Tables (.zip) 
Updated November 2, 2012

 2013 NDC Lists

Medication Table

Adherence to Antipsychotic Medications for Individuals with Schizophrenia (SAA)

   

Table SAA-A: Antipsychotic MedicationsDA

Table SAA-A.xls

 No changes. Refer to the table in the publication.

Annual Monitoring for Patients on Persistent Medications (MPM)    

Table MPM-B: Drugs to Identify Members on Digoxin

Note: This table is also used for: 
Accountable Care Organizations: Table AMPM-B.

Table MPM-B.xls 

No changes. Refer to the table in the publication. 

Table MPM-C: Drugs to Identify Members on Diuretics

Note: This table is also used for:
Accountable Care Organizations: Table AMPM-C. 

Table MPM-C.xls 

No changes. Refer to the table in the publication. 

Table MPM-D: Drugs to Identify Members on Anticonvulsants

Note: This table is also used for:
Accountable Care Organizations: Table AMPM-D. 

Table MPM-D. xls 

No changes. Refer to the table in the publication.

Antibiotic Utilization (ABX)     
Table ABX-A: Antibiotic Medications 

Table ABX-A.xls 

Table ABX-A.doc 

Table ABX-B: Antibiotic of Concern by NCQA Drug Class 

 Table ABX-B.xls

Table ABX-B.doc 

Table ABX-C: All Other Antibiotics by NCQA Drug Class 

Table ABX-C.xls 

Table ABX-C.doc 

Antidepressant Medications Management (AMM)     

Table AMM-C: Antidepressant Medications

Note: This table is also used for:
Accountable Care Organizations: Table AAMM-C 

Table AMM-C.xls 

No changes. Refer to the table in the publication.  

Appropriate Treatment for Children with Pharyngitis (CWP)     

Table CWP-C: Antibiotic Medications

Note: This table is also used for:
Accountable Care Organizations: Table ACWP-C. 

Table CWP-C. xls 

Table CWP-C.doc 

Asthma Medication Ratio (AMR)     
Table AMR-A: Asthma Controller and Reliever Medications 

Table AMR-A.xls 

Table AMR-A.doc 

Avoidance of Antibiotic Treatment for Adults with Acute Bronchitis (AAB)     

Table AAB-D: : Antibiotic Medications

Note: This table is also used for:
Accountable Care Organizations: Table AAAB-D.

Table AAB-D.xls 

Table AAB-D.doc 

Chlamydia Screening in Women (CHL)     

Table CHL-A: Prescriptions to Identify Contraceptives

Note: This table is also used for:
Accountable Care Organizations: Table ACHL-A. 

Table CHL-A.xls 

No changes. Refer to the table in the publication. 

Table CHL-E: Medication to Identify Exclusions

Note: This table is also used for:
Accountable Care Organizations:Table ACHL-D. 

Table CHL-E. xls 

No changes. Refer to the table in the publication. 

Comprehensive Diabetes Care (CDC)     

Table CDC-A: Prescriptions to Identify Members with Diabetes

Note: This table is also used for:
Accountable Care Organizations: Table ACDC-A;
Disease Management: Table DCDC-A. 

Table CDC-A.xls 

Table CDC-A.doc 

Table CDC-L: ACE Inhibitors/ARBs

Note: This table is also used for:
Accountable Care Organizations: Table ACDC-M;
Disease Management: Table DCDC-P. 

Table CDC-L.xls 

No changes. Refer to the table in the publication. 

Comprehensive Ischemic Vascular Disease Care (IVD)     

Table IVD-E: Oral Anti-Platelet Therapies

Note: This table is only applicable to the Technical Specifications for Physician Measurement. 

Table IVD-E. xls 

No changes. Refer to the table in the publication.

Management of People with Ischemic Vascular Disease (DIVD)     

Table DIVD-G: Aspirin or Other Antithrombotic Medications

Note: This table is only applicable to the Technical Specifications for Disease Management. 

Table DIVD-G.xls 

 No changes. Refer to the table in the publication.

Diabetes Screening for People With Schizophrenia or Bipolar Who Are Using Antipsychotic Medications (SSD)     
Table SSD-D: Antipsychotic Medications 

Table SSD-D.xls 

No changes. Refer to the table in the publication. 

Disease Modifying Anti-Rheumatic Drug Therapy (ART)     

Table ART-C: DMARDs

Note: This table is also used for:
Accountable Care Organizations: Table AART-D. 

Table ART-C.xls 

No changes. Refer to the table in the publication. 

Follow-Up Care for Children Prescribed ADHD Medication (ADD)     

Table ADD-A: ADHD Medications

Note: This table is also used for:
Accountable Care Organizations: Table AADD-A. 

Table ADD-A.xls 

No changes. Refer to the table in the publication. 

Osteoporosis Management in Women Who had a Fracture (OMW)     

Table OMW-C: FDA-Approved Osteoporosis Therapies

Note: This table is also used for:
Accountable Care Organizations: Table AOMW-D. 

Table OMW-C.xls 

No changes. Refer to the table in the publication. 

Persistence of BB Treatment After a Heart Attack (PBH)     

Table PBH-B: Beta-Blocker Medications

Note: This table is also used for:
Disease Management: Table DPBH-B. 

Table PBH-B.xls 

 No changes. Refer to the table in the publication.

Table PBH-D: Medications to Identify Exclusion (History of Asthma)

Note: This table is also used for:
Disease Management: Table DPBH-D. 

Table PBH-D.xls 

No changes. Refer to the table in the publication. 

Pharmacotherapy Management of COPD Exacerbation (PCE)     
Table PCE-C: Systemic Corticosteroids 

Table PCE-C.xls 

No changes. Refer to the table in the publication. 

Table PCE-D: Bronchodilators 

Table PCE-D.xls 

Table PCE-D.doc 

Potentially Harmful Drug-Disease Interactions in the Elderly (DDE)      

Table DDE-C: Tricyclic Antidepressants

Note: This table is also used for:
Accountable Care Organizations: Table ADDE-C. 

Table DDE-C.xls 

No changes. Refer to the table in the publication. 

Table DDE-D: Antipsychotics and Sleep Agents

Note: This table is also used for:
Accountable Care Organizations: Table ADDE-D. 

Table DDE-D.xls 

No changes. Refer to the table in the publication. 

Table DDE-F: Medications for Dementia

Note: This table is also used for:
Accountable Care Organizations: Table ADDE-F. 

Table DDE-F.xls 

No changes. Refer to the table in the publication. 

Table DDE-G: Anticholingeric Agents

Note: This table is also used for:
Accountable Care Organizations: Table ADDE-G. 

Table DDE-G.xls 

Table DDE-G.doc 

Table DDE-I: NSAIDs and Cox-2 Selective NSAIDs

Note: This table is also used for:
Accountable Care Organizations: Table ADDE-I.

Table DDE-I.xls 

 No changes. Refer to the table in the publication.

 Use of Appropriate Medications for People with Asthma (ASM)    

Table ASM-C: Asthma Medications

Note: This table is also used for:
Accountable Care Organizations: Table AASM-C;
Disease Management: Table DASM-C.

 Table ASM-C.xls

 Table ASM-C.doc

Table ASM-D: Asthma Controller Medications

Note: This table is also used for:
Accountable Care Organizations: Table AASM:E;
Disease Management: Table DASM-E. 

 Table ASM-D.xls

 Table ASM-D.doc

Use of High-Risk Medications in the Elderly (DAE)     

Table Table DAE-A: High-Risk Medications (Updated November 2, 2012)

Note: This table is also used for:
Accountable Care Organizations: Table ADAE-A. 

Table DAE-A.xls 

 Table DAE-A.doc

Table DAE-B: High-Risk Medications with Days Supply Criteria

Note: This table is also used for:
Accountable Care Organizations: Table ADAE-B. 

 Table DAE-B.xls

 No changes. Refer to the table in the publication.

Table DAE-C: High-Risk Medications with Average Daily Dose Criteria

Note: This table is also used for:
Accountable Care Organizations: Table ADAE-C. 

 Table DAE-C.xls

 No changes. Refer to the table in the publication.